Release date: 2007-07-20
In response to growing concerns, the government has announced plans to enhance regulatory oversight of the pharmaceutical sector. This move is expected to bring greater standardization and long-term sustainability to the industry. While the growth rate of the pharmaceutical industry in 2006 slowed compared to previous years, it still outperformed the overall GDP growth. These insights were shared by Mr. Tao Jianhong, Deputy Director of the Southern Pharmaceutical Economic Research Institute, during a recent event titled “New Challenges and New Opportunities†hosted by the “Times Health†Customer Association on July 11th.
The forum brought together representatives from pharmaceutical companies, government agencies, and the Southern Institute of Medicine and Economics. Discussions focused on new strategies for media and pharmaceutical collaboration, as well as the future of industry development and promotion. Despite challenges faced over the past two years, participants agreed that the pharmaceutical market remains full of potential opportunities.
Government efforts have intensified in monitoring and regulating the industry, aiming to guide it toward a more structured and sustainable path. Recently, Guangdong Province has seen a rise in the exposure of illegal drug advertisements, with stricter enforcement measures being implemented. This shift in advertising practices has caused significant disruption within the industry, forcing companies to rethink their strategies. Zhou Zhimin, Deputy Director of the Advertising Management Department at the Guangzhou Administration for Industry and Commerce, emphasized that the goal of increased regulation is not to hinder pharmaceutical companies but to push them toward a healthier and more professional direction. This message provided much-needed reassurance to many in the room.
Meanwhile, leveraging the strengths of media and healthcare networks has become a key strategy for finding solutions. He Zhaoxi, President of the Information Times, highlighted the publication’s positive growth in recent years, including its recognition at the World Press Association annual meeting in Cape Town, South Africa, where it ranked 29th among the top 100 most circulated newspapers worldwide in 2007. He also expressed hope that through collaborative efforts with medical professionals, the Information Times could help the pharmaceutical industry navigate these difficult times and discover new paths forward. (Sohu)
Luteolin, alias carotenoid, carotenol, phytoalexin, riboflavin, marigoldin and phytoalexin, etc., orange-yellow powder. Natural lutein is an excellent antioxidant. Lutein and zeaxanthin are the only 2 carotenoids in the eye, and the prevention of vision loss and blindness caused by age-related retinal macular degeneration is the unique function of lutein.
Natural lutein is an excellent antioxidant, can resist free radicals in the body caused by cell and organ damage, thus can prevent the body aging caused by cardiovascular sclerosis, coronary heart disease and tumor disease.
Lutein,Lutein Ester,Xanthophyll,Carotenoids
Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyiherbs.com